trending Market Intelligence /marketintelligence/en/news-insights/trending/p-i3HvoboroBGfAwXCRajg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

OptimizeRx director resigns

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


OptimizeRx director resigns

OptimizeRx Corp. said board member Bryan Archambault resigned.

Archambault has been a director of the company since March. With the resignation, Archambault also resigned as a member of the board's audit, nomination and governance committees.

The Rochester, Mich.-based company said independent directors Patrick Spangler, James Lang and Ellen O'Connor Vos are expected to fill the roles left vacant by Archambault's departure.

The company operates a digital health messaging platform by using electronic health records to connect drugmakers with healthcare services providers.